| Literature DB >> 31114655 |
Elham Ashrafi1, Seyed-Farzad Mohammadi1, Marzieh Katibeh2,3, Ebrahim Ghaderi4, Cyrus Alinia5, Naser Nourmohammadi1, Alireza Lashay1, Ramin Beiranvand3,6, Mahsa Yousefpour Marzbali1, Ali Sadeghi Tari1.
Abstract
PURPOSE: To determine the magnitude and causes of blindness and visual impairment (VI) in Kurdistan, using the Rapid Assessment of Avoidable Blindness methodology.Entities:
Keywords: Blindness; Iran; Kurdistan; Prevalence; Visual Impairment
Year: 2019 PMID: 31114655 PMCID: PMC6504726 DOI: 10.4103/jovr.jovr_220_17
Source DB: PubMed Journal: J Ophthalmic Vis Res ISSN: 2008-322X
Age and gender distribution of examined people and Kurdistan population
| Age groups | (Sample) Male | (Population) Male | (Sample) Female | (Population) Female | (Sample) Total | Total (Population) |
|---|---|---|---|---|---|---|
| 50-59 years | 653 (42.2) | 59,408 (50) | 826 (49.8) | 59,094 (49.4) | 1,479 (46) | 118,502 (49.6) |
| 60-69 years | 509 (32.9) | 29,372 (24.7) | 513 (31) | 33,470 (27.9) | 1,022 (32) | 62,842 (26.3) |
| 70-79 years | 245 (15.8) | 20,332 (17.1) | 221 (13.3) | 18,962 (15.8) | 466 (14.6) | 392,93 (16.5) |
| 80+ years | 139 (9) | 9,768 (8.2) | 97 (5.9) | 8,316 (6.9) | 236 (7.5) | 180,84 (7.6) |
| Total | 1,546 (100) | 118,880 (100) | 1,657 (100) | 119,842 (100) | 3,203 (100) | 238,722 (100) |
Standardized prevalence of blindness, Severe Visual Impairment (SVI) and Moderate Visual Impairment (MVI) - bilateral Presenting Visual Acuity (PVA)
| Male % (95% CI) | Female % (95% CI) | Total % (95% CI) | OR* (95% CI)** | ||||
|---|---|---|---|---|---|---|---|
| Adjusted Prevalence | Cumulative prevalence | Adjusted Prevalence | Cumulative prevalence | Adjusted Prevalence | Cumulative prevalence | ||
| Blindness | 2.0 (1.4-2.7) | 2.0 (1.4-2.7) | 2.1 (1.4-2.8) | 2.1 (1.4-2.8) | 2.1 (1.5-2.6) | 2.1 (1.5-2.6) | 1.01 (0.61-1.68) |
| SVI | 1.5 (0.9-2.0) | 3.5 (2.6-4.4) | 1.9 (1.1-2.7) | 4.0 (2.9-5.2) | 1.7 (1.2-2.2) | 3.8 (2.9-4.6) | 0.83 (0.48-1.45) |
| MVI | 9.5 (7.9-11.0) | 12.9 (11.1-14.7) | 9.8 (8.2-11.4) | 13.8 (11.7-15.9) | 9.6 (8.4-10.8) | 13.8 (11.4-15) | 0.99 (0.78-1.26) |
| Functional Low Vision | 4.4 (3.4-5.4) | 2.6 (1.9-3.3) | 3.5 (2.8-4.1) | 1.65 (1.12-2.43) | |||
*OR, Odds Ratio Male/Female; **CI, confidence interval
Blindness prevalence by age group and sex in studied sample
| Age groups | Male | Female | Total | |||
|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | ||||
| 50-59 years | 3 | 0.5 (0.0-1.0) | 6 | 0.7 (0.2-1.3) | 9 | 0.6 (0.2-1.0) |
| 60-69 years | 4 | 0.8 (0.0-1.5) | 4 | 0.8 (0.0-1.5) | 8 | 0.8 (0.2-1.4) |
| 70-79 years | 10 | 4.1 (1.7-6.5) | 8 | 3.6 (1.0-6.2) | 18 | 3.9 (2.0-5.7) |
| 80+ years | 14 | 10.1 (5.4-14.7) | 13 | 13.4 (6.3-20.5) | 27 | 11.4 (7.3-15.5) |
| Total | 31 | 2.0 (1.3-2.7) | 31 | 1.9 (1.1-2.6) | 62 | 1.9 (1.4-2.5) |
Standardized prevalence of blindness, Severe Visual Impairment (SVI) and Moderate Visual Impairment (MVI) by Urban/Rural
| Urban | Rural | Total | OR*(95% CI)** | ||||
|---|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | |||||
| Blindness | 44 | 2.1 (1.4-2.7) | 18 | 1.6 (0.9-2.3) | 62 | 1.9 (1.4-2.5) | 1.2 (0.7-2.1) |
| SVI | 19 | 0.9 (0.5-1.3) | 32 | 2.9 (1.9-3.9) | 51 | 1.6 (1.1-2.1) | 0.3 (0.2-0.5) |
| MVI | 194 | 9.2 (8.0-10.4) | 107 | 9.8 (8.0-11.6) | 301 | 9.4 (8.2-10.6) | 0.9 (0.7-1.1) |
| Functional Low Vision | 82 | 3.9 (2.7-4.3) | 30 | 2.7 (1.7-3.7) | 112 | 3.5 (2.8-4.1) | 1.4 (0.9-2.1) |
OR, Odds Ratio Urban/Rural; **CI, confidence interval
Principal cause of blindness, Severe Visual Impairment (SVI) and Moderate Visual Impairment (MVI) in persons
| Blindness | SVI | MVI | ||||
|---|---|---|---|---|---|---|
| % | % | % | ||||
| Refractive error | 1 | 1.6 | 2 | 3.9 | 112 | 37.2 |
| Uncorrected Aphakia | 0 | 0 | 0 | 0 | 0 | 0 |
| Untreated Cataract | 17 | 27.4 | 31 | 60.8 | 101 | 33.6 |
| Cataract surgical complications | 0 | 0 | 2 | 3.9 | 9 | 3 |
| Trachomatous corneal opacity | 6 | 9.7 | 2 | 3.9 | 5 | 1.7 |
| Non Trachomatous corneal opacity | 5 | 8.1 | 2 | 3.9 | 17 | 5.6 |
| Phthisis | 0 | 0 | 0 | 0 | 0 | 0 |
| Glaucoma | 5 | 8.1 | 1 | 2 | 1 | 0.3 |
| Diabetic retinopathy | 2 | 3.2 | 0 | 0 | 6 | 2 |
| ARMD | 16 | 25.8 | 7 | 13.7 | 39 | 13 |
| Other posterior segment disease | 8 | 12.9 | 4 | 7.8 | 10 | 3.3 |
| All other globe/CNS abnormalities | 2 | 3.2 | 0 | 0 | 1 | 0.3 |
ARMD, age related macular degeneration; CNS, central neural system; SVI, severe visual impairment; MVI, moderate visual impairment
Figure 1Distribution of avoidable causes of blindness, severe visual impairment (SVI), and moderate visual impairment (MVI).